Verallia stock gains after BNP Paribas cuts price target

Published on 09/19/2026 at 13:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Verallia stock closed at EUR 19.12 on September 17, 2026 on Euronext Paris after a 2.36 percent rise. BNP Paribas lowered its price target to EUR 19.50 from EUR 21.00 on September 18, 2026 while keeping a Neutral rating.

Glasfabrik mit Flaschen auf Fließband vor glühendem Schmelzofen — Verallia SA (ISIN FR0013506730) produziert Glasflaschen in modernen Fabriken mit Schmelzöfen und Fließbändern effizient, Illustration mit AI erstellt.

Verallia stock (ISIN FR0013506730) closed at EUR 19.12 on September 17, 2026 on Euronext Paris, up 2.36 percent from the prior session, after BNP Paribas cut its price target to EUR 19.50 from EUR 21.00 while maintaining a Neutral stance as reported on September 18, 2026.

BNP Paribas adjusts target but keeps Neutral rating

According to Ad-hoc-news on September 18, 2026, BNP Paribas confirmed its Neutral rating on Verallia and lowered the 12-month price target to EUR 19.50 from EUR 21.00.

The new target of EUR 19.50 now sits just 0.38 EUR, or about 2.0 percent, above the EUR 19.12 closing price recorded on September 17, 2026, indicating that the broker sees only limited upside based on current fundamentals and valuation.

As the same overview cites via Ad-hoc-news, a three-month analyst consensus target compiled by Boursorama stood at EUR 21.43 as of August 18, 2026, implying around 12.1 percent upside from the same EUR 19.12 reference level and highlighting that BNP Paribas is now more cautious than the broader analyst community.

Recent share performance and trading range

Price data from Euronext Paris quoted by Boursorama show that Verallia shares finished at EUR 18.86 on September 18, 2026, down 1.36 percent on the day, after reaching an intraday high of EUR 19.20 and a low of EUR 18.58.

Over the five trading sessions from September 14 to September 18, 2026, Boursorama data indicate that Verallia traded between EUR 18.32 and EUR 19.25, with the closing price rising from EUR 18.44 to EUR 18.86, corresponding to a five-day gain of 2.28 percent.

The same snapshot referenced by Ad-hoc-news reports that Verallia stock was down 20.16 percent over the preceding 12 months and 16.75 percent year to date as of mid August 2026, underlining that the recent short-term recovery comes after a more prolonged period of weakness.

Fundamentals and upcoming earnings date

While the latest analyst moves are now in focus, investors are also looking ahead to the next set of figures. According to the analyst and data summary cited by Ad-hoc-news, Boursorama lists October 27, 2026 as the next earnings date for Verallia, when the company is expected to present new quarterly or nine-month results.

In that same overview, Verallia is described as a materials and packaging company with a market capitalization of EUR 2.24 billion as of September 17, 2026, based on the EUR 19.12 share price on Euronext Paris and the number of shares outstanding.

The consensus target of EUR 21.43 as of August 18, 2026 compared with the GBP-neutral BNP Paribas target of EUR 19.50 illustrates that some analysts still project upside of roughly 12 percent from the EUR 19.12 level, while others see the stock as closer to fairly valued.

Index context and sector positioning

Beyond the single stock view, the broader French equity context has recently shifted. As MarketScreener reported in an Euronext index update on September 10, 2026, Verallia was excluded from the SBF120 index when Euronext included Genfit and Inventiva, a move that can influence index-linked flows and visibility for the stock.

From an investor perspective, the combination of index exclusion, a cautious new target from BNP Paribas and a still-depressed 12-month performance profile frames Verallia as a packaging name where sentiment has been mixed, even as the shares have gained modestly in recent sessions.

Verallia stock price snapshot

Verallia stock last closed at EUR 18.86 on September 18, 2026 on Euronext Paris, with a one-day decline of 1.36 percent following the prior close of EUR 19.12, and a five-day rise of 2.28 percent over the period from September 14 to September 18, 2026.